DRUG ANG1005-CLN-07 - A Randomized Open-Label, Multi-Center Pivotal Study of ANG1005 Compared with Physician’s Best Choice in HER2-Negative Breast Cancer Patients with Newly Diagnosed Leptomeningeal Carcinomatosis and Previously Treated Brain Metastases

Project: Research project

Project Details

StatusActive
Effective start/end date4/1/194/1/22

Funding

  • AngioChem Inc. (ANG1005-CLN-07)